AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Beauty Health Co (NASDAQ:SKIN)
0.84 USD
+0.019 2.252%Sponsored Reports
Loading...
| Previous Close (in USD) | 0.8215 |
|---|---|
| Change | +0.019 2.252% |
| 52 W H/L (in USD) | 9.730/1.350 |
| EBITDA (in USD) | -93.531M |
| PE Ratio | -- |
| Volume | 612975 |
| Diluted Eps TTM | -0.71 |
| Total Assets (in USD) | 929.113M |
|---|---|
| Total Liabilities (in USD) | 869.723M |
| Revenue TTM (in USD) | 393.116M |
| Cash (in USD) | 523.025M |
| Market Cap (in USD) | 311.553 M |
| Revenue Per Share TTM | 3.039 |
| Gross Profit TTM (in USD) | 250.34M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Beauty Health Co
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Employees: 881
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Brenton L. Saunders J.D. | Exec. Chairman | 1970 |
| 2. | Ms. Liyuan Woo | Chief Financial Officer | 1972 |
| 3. | Mr. Daniel Copell Watson | Exec. VP of Americas Sales | 1962 |
| 4. | Mr. Andrew Stanleick | Pres, CEO & Director | 1971 |
| 5. | Eduardo Rodriguez | Sr. Director of M&A and Investor Relations | NA |
| 6. | Mr. Paul Bokota | VP & Gen. Counsel | NA |
| 7. | Ms. Kellie Sears | Chief HR Officer | NA |
| 8. | Dr. Jwala Karnik M.D. | Exec. VP of Strategy & Partnership | NA |
| 9. | Mr. Benjamin C. Baum | Chief Experience Officer | 1973 |
| 10. | Mr. Mingo Ku | Pres of North Asia | NA |
Peers
Sector: Consumer Defensive
Industry: Household & Personal Products
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
PG
Procter & Gamble Company |
-1.520 1.003% | 152.86 | 23.580 | 22.624 | 4.074 | 7.235 | 4.397 | 16.081 |
|
LRLCF
L'Oréal S.A |
+6.140 1.418% | 432.88 | 41.140 | 34.247 | 6.519 | 8.594 | 6.671 | 27.760 |
|
LRLCY
L’Oreal Co ADR |
+0.230 0.265% | 86.96 | 41.270 | 33.898 | 6.564 | 8.499 | 6.649 | 27.669 |
|
UNLYF
Unilever PLC |
+1.200 1.974% | 61.99 | 21.170 | 17.331 | 2.437 | 6.756 | 2.660 | 12.909 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | 45.032M | -377.35M | -38.483M | -2.935M | 0.01M |
| Minority Interest | - | - | - | - | - |
| Net Income | 44.384M | -375.108M | -29.175M | -1.638M | -0.317M |
| Selling General Administrative | 106.1M | 98.688M | 30.649M | 26.662M | 17.772M |
| Gross Profit | 250.34M | 181.827M | 67.199M | 106.512M | 72.975M |
| Reconciled Depreciation | 22.016M | 21.282M | 14.533M | 13.944M | 11.496M |
| Ebit | -24.28M | -36.639M | -17.182M | 13.462M | 10.051M |
| Ebitda | -16.755M | -88.189M | -2.828M | 27.878M | 21.547M |
| Depreciation And Amortization | 7.525M | -51.55M | 14.354M | 14.416M | 11.496M |
| Operating Income | -24.28M | -36.639M | -17.182M | 13.462M | 10.06M |
| Other Operating Expenses | 390.156M | 296.725M | 136.274M | 153.161M | 102.25M |
| Interest Expense | 13.392M | 11.777M | 21.275M | 17.092M | 10.049M |
| Tax Provision | 0.648M | -2.242M | -9.308M | -1.297M | 0.327M |
| Interest Income | 9.175M | - | 36.688M | - | - |
| Net Interest Income | -4.217M | -11.777M | -21.275M | -17.092M | -10.049M |
| Income Tax Expense | 0.648M | -2.242M | -9.308M | -1.297M | 0.327M |
| Total Revenue | 365.876M | 260.086M | 119.092M | 166.623M | 112.31M |
| Total Operating Expenses | 274.62M | 218.466M | 84.381M | 93.05M | 62.915M |
| Cost Of Revenue | 115.536M | 78.259M | 51.893M | 60.111M | 39.335M |
| Total Other Income Expense Net | 69.312M | -340.711M | -21.301M | -16.397M | -0.001M |
| Net Income From Continuing Ops | 44.384M | -375.108M | -29.175M | -1.638M | -0.317M |
| Net Income Applicable To Common Shares | 44.384M | -375.108M | -29.915M | -2.359M | -90.929M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 929.113M | 1008.907M | 1218.806M | 222.835M | 226.351M |
| Intangible Assets | 62.123M | 46.386M | 56.01M | 50.935M | 60.293M |
| Other Current Assets | 13.877M | 26.698M | 12.322M | 3.22M | 3.709M |
| Total Liab | 869.723M | 837.431M | 916.509M | 252.795M | 227.559M |
| Total Stockholder Equity | 59.39M | 171.476M | 302.297M | -29.96M | -1.208M |
| Other Current Liab | 62.883M | 37.007M | 3.712M | 11.933M | 0.144M |
| Common Stock | 0.012M | 0.014M | 0.016M | 376.491M | - |
| Capital Stock | 0.012M | 0.014M | 0.016M | 0M | 0M |
| Retained Earnings | -478.867M | -374.328M | -418.712M | -43.604M | -14.429M |
| Good Will | 125.818M | 124.593M | 123.694M | 98.531M | 98.52M |
| Other Assets | - | 15.008M | 7.035M | 5.083M | 2.568M |
| Cash | 523.025M | 568.197M | 901.886M | 9.486M | 7.307M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 115.008M | 73.115M | 76.437M | 30.93M | 37.818M |
| Current Deferred Revenue | 2.759M | 0.815M | 39.964M | - | 14.49M |
| Net Debt | 229.264M | 183.593M | -171.972M | 207.05M | 182.47M |
| Short Term Debt | 4.598M | 4.958M | 3.712M | 0.512M | 8.927M |
| Short Long Term Debt | - | - | - | 0.512M | 8.927M |
| Short Long Term Debt Total | 752.289M | 751.79M | 729.914M | 216.536M | 189.777M |
| Other Stockholder Equity | 541.281M | 550.32M | 722.25M | 13.402M | 13.193M |
| Property Plant Equipment | - | 33.821M | 31.175M | 9.191M | 10.8M |
| Total Current Assets | 698.252M | 789.099M | 1000.892M | 59.095M | 54.17M |
| Long Term Investments | - | - | - | 460.098M | - |
| Short Term Investments | - | - | - | -0.021M | - |
| Net Receivables | 70.029M | 77.774M | 51.423M | 23.187M | 23.719M |
| Long Term Debt | 738.372M | 734.143M | 729.914M | 216.024M | 180.85M |
| Inventory | 91.321M | 116.43M | 35.261M | 23.202M | 19.435M |
| Accounts Payable | 44.768M | 30.335M | 29.049M | 18.485M | 14.257M |
| Accumulated Other Comprehensive Income | -3.036M | -4.53M | -1.257M | 0.242M | 0.028M |
| Non Currrent Assets Other | 16.043M | 14.193M | 6.705M | 4.813M | 2.336M |
| Non Current Assets Total | 230.861M | 219.808M | 217.914M | 163.74M | 172.181M |
| Capital Lease Obligations | 13.917M | 17.647M | 16.493M | 0M | 0.42M |
| Long Term Debt Total | - | 734.143M | 729.914M | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | -18.869M | 0.781M | -3.817M | -12.48M | -8.443M |
| Total Cashflows From Investing Activities | -18.869M | -37.731M | -3.817M | -12.48M | -8.443M |
| Total Cash From Financing Activities | -205.242M | 959.035M | 18.273M | 14.578M | 11.164M |
| Net Income | 44.384M | -375.108M | -29.175M | -1.638M | -0.317M |
| Change In Cash | -333.689M | 892.4M | 2.179M | 3.732M | 1.823M |
| Begin Period Cash Flow | 901.886M | 9.486M | 7.307M | 3.575M | 1.752M |
| End Period Cash Flow | 568.197M | 901.886M | 9.486M | 7.307M | 3.575M |
| Total Cash From Operating Activities | -106.6M | -28.361M | -12.436M | 1.728M | -0.895M |
| Depreciation | 22.016M | 21.135M | 14.401M | 13.881M | 11.496M |
| Other Cashflows From Investing Activities | -8.022M | -27.311M | -460M | 0.781M | -0.558M |
| Dividends Paid | - | - | 0M | 0M | 98.711M |
| Change To Inventory | -82.097M | -9.443M | -3.211M | -4.769M | -9.799M |
| Sale Purchase Of Stock | -160M | 188.378M | -0.154M | 0M | 0M |
| Other Cashflows From Financing Activities | -45.742M | 1189.521M | 35.199M | 26.578M | 114.903M |
| Capital Expenditures | 17.394M | 15.616M | 3.817M | 10.422M | 7.885M |
| Change In Working Capital | -140.283M | -18.664M | -2.582M | -7.912M | -9.78M |
| Other Non Cash Items | -59.425M | 335.621M | 8.898M | 1.943M | 0.66M |
| Free Cash Flow | -123.994M | -43.977M | -16.253M | -8.694M | -8.78M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Janus Henderson Contrarian D | 2 years ago | 11117965 |
| 2. | Janus Henderson US Opportunistic Alpha | 2 years ago | 11117965 |
| 3. | Fidelity Growth Compy Commingled Pl O | 2 years ago | 5959647 |
| 4. | Fidelity Growth Company Fund | 2 years ago | 4295576 |
| 5. | Vanguard Total Stock Mkt Idx Inv | 2 years ago | 2698071 |
| 6. | iShares Russell 2000 ETF | 2 years ago | 1874834 |
| 7. | Fidelity Growth Company K6 | 2 years ago | 1588618 |
| 8. | Vanguard Institutional Extnd Mkt Idx Tr | 2 years ago | 1257350 |
| 9. | Fidelity Series Growth Company | 2 years ago | 1191398 |
| 10. | Vanguard Consumer Staples ETF | 2 years ago | 943097 |
| 11. | Fidelity Small Cap Index | 2 years ago | 829756 |
| 12. | iShares Russell 2000 Growth ETF | 2 years ago | 678060 |
| 13. | State St Russell Sm/Mid Cp® Indx NL Cl C | 2 years ago | 486050 |
| 14. | Fidelity Extended Market Index | 2 years ago | 468254 |
| 15. | Schwab US Small-Cap ETF™ | 2 years ago | 386686 |
| 16. | Wellington SMID Cap Research Equity | 2 years ago | 378355 |
| 17. | State St Russell Sm Cap® Indx SL Cl I | 2 years ago | 313262 |
| 18. | Vanguard Russell 2000 ETF | 2 years ago | 301066 |
| 19. | NT R2000 Growth Index Fund - NL | 2 years ago | 245671 |
| 20. | NT R2000 Index Fund - NL | 2 years ago | 224511 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | FMR Inc | 2 years ago | 16786185 |
| 2. | HHG PLC | 2 years ago | 11286468 |
| 3. | Luxor Capital Group, LP | 2 years ago | 6813467 |
| 4. | Morgan Stanley - Brokerage Accounts | 2 years ago | 6290255 |
| 5. | BlackRock Inc | 2 years ago | 6175588 |
| 6. | Vanguard Group Inc | 2 years ago | 5557689 |
| 7. | Divisadero Street Capital Management, LP | 2 years ago | 4874566 |
| 8. | Camber Capital Management LLC | 2 years ago | 3500000 |
| 9. | Woodline Partners LP | 2 years ago | 3125316 |
| 10. | Geode Capital Management, LLC | 2 years ago | 1875626 |
| 11. | State Street Corporation | 2 years ago | 1758354 |
| 12. | Silver Point Capital LP | 2 years ago | 1592030 |
| 13. | D. E. Shaw & Co LP | 2 years ago | 1429672 |
| 14. | Ararat Capital Management, LP | 2 years ago | 1111406 |
| 15. | Jacobs Levy Equity Management, Inc. | 2 years ago | 967755 |
| 16. | Goldman Sachs Group Inc | 2 years ago | 946870 |
| 17. | Northern Trust Corp | 2 years ago | 783308 |
| 18. | Charles Schwab Investment Management Inc | 2 years ago | 647701 |
| 19. | JANE STREET GROUP, LLC | 2 years ago | 646050 |
| 20. | Glendon Capital Management LP | 2 years ago | 636954 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...